-
'Go Red for Women' campaign targets deadly disease.
The article focuses on the campaign organized by the American Heart Association Inc. for cardiovascular disease prevention in women. The campaign, called the "Go Red for Women," is raising awareness about the dangers of the disease, in which red symbolizes healthy eating, exercise and focusing on risk factors. The disease has been the leading cause of morbidity and mortality, as well as the cause of disability in women. Risk factors for the disease include smoking, hypertension and diabetes.
-
'It's a good time to be a pharmacist'.
The article reports on the increase of salary for physicians, according to the 2006 Pharmacy Compensation Survey by Mercer Human Resource Consulting Inc. Physician Eric Michael asserted that pharmacy professionals have the highest wage growth of 4.5% among other professions. The change of pay rate was due to pharmacist shortage and high demand of pharmacy services.
-
'Medicines in My Home': Educational program teaches children.
The article examines the Medicines in My Home program started by the U.S. Department of Health and Human Services to teach sixth-grade students about over the counter (OTC) medication. The program aims to encourage children to discuss the information with their families. Several guidelines were also enumerated regarding the use of OTC. On the other hand, one survey found that 1 in 5 teenager has abused prescription medications.
-
'State of the Art': New research advances GI health.
The article reports on the advances in gastrointestinal (GI) research, as discussed at the "Digestive Diseases Week" 2006 in Los Angeles, California. Among the innovations include are novel therapy mixes for hepatitis C infections, biologic therapies for stimulating remission in slight to severe Crohn's disease, and the use of Angiotensin converting enzyme (ACE) inhibitors for minimizing the risk of some GI cancers.
-
'What have you done for me lately?'.
The article highlights the achievements and efforts of the American Pharmacists Association (APhA) in the U.S. from 2005-2006. The APhA has updated its Web site for changes brought about by the Medicare Prescription Drug, Improvement, and Modernization Act. Former APhA trustee Timothy Tucker attested on Part D enforcement during a House Government Reform Committee Democratic briefing. The APhA also coordinated with pharmacist, payor, and prescriber groups to develop standard Part D claims.
-
2006 APhA election results.
The article announces the 2006 election results of the American Pharmacists Association for its newly elected officers and trustees. The Association's president-elect is Timothy L. Tucker who has served as president of the Tennessee Pharmacists Association and the Tennessee Board of Pharmacy. Among the new members of the Board of Trustees are Matthew C. Osterhaus from Iowa and Dick R. Gourley who is a professor and dean at the University of Tennessee Health Science Center.
-
2006 Progress Report Card shows improved balance in state pain policies.
The article provides information on the report card entitled "Achieving Balance in State Pain Policy: A Progress Report Card" released by the Pain &Policy Studies Group of the University of Wisconsin. It reveals that some states in the U.S. have passed laws that attempt to protect health care providers who treat pain patients. Several states also have initiatives designed to improve pain management education and awareness of state policies among health care providers.
-
340B Prime Vendor Program reduces burden of soaring drug prices.
The article reports on the implementation of 340B Prime Vendor Program (PVP) by the U.S. Health Resources and Services Administration (HRSA). HRSA aims to control the increasing cost of pharmaceuticals by providing financial relief 340B-eligible entities. PVP has been approved by law and it is a key component of the 340 Drug Discount Program.
-
A novel oral triazole antifungal: Posaconazole.
The article evaluates noxafil from Schering-Plough Corp. and offers information and about its applications and content.
-
A Pharmacist's Guide to Using the Orange Book for Product Substitution Decisions.
The article reviews the book "The Orange Book."
-
A plan B for pharmacy.
The article discusses various reports published within the issue, including the need for patients to know a pharmacists capabilities and services and how to accomplish the patient education and care realms.
-
A renewed interest in compounding.
The article focuses on the pharmacist compounding, a core element of the practice of pharmacy, which has gained congressional interest. A briefing for Hill staff on pharmacist compounding was co-sponsored by the U.S. legislators. The briefing was designed to educate staff about the topic including the concerns several groups have expressed to Food and Drug Administration and the concerns of a hospital that has experienced problems.
-
About One to One.
The article reports on the launching of the Pharmacy Today One to One Patient Counseling Recognition Program in 2003 in the U.S. The program was supported by Johnson &Johnson—Merck Consumer Pharmaceuticals. Pharmacists are nominated for their performance in one-to-one communication with patients which will be reviewed by previous winners.
-
Accelerated approval for panitumumab.
The article evaluates Vectibix from Amgen Inc. and offers about its application and therapeutic effects.
-
Acute otitis media: Painful to say the least!
The article offers information on acute otitis media. It is a very common pediatric ailment in the U.S. and is likely to develop among boys and those younger than 2 years old who attend day care, are exposed to secondary hand smoke, are exposed to second-hand smoke, are formula fed, are fed in a supine position, and have craniofacial abnormalities. The first-line treatments for the ear pain known as otalgia include oral analgesics such as aminophen and ibuprofen.
-
Advancing pharmacy during congressional change.
The article focuses on the advancement of pharmacy during the transition of leadership in the U.S. The author asserted that their should be a persistent advocacy in the legislative agenda of pharmacy through bipartisan initiative. There should be good policies intended for the development of pharmacy regardless of what party dominates after the November 2006 elections.
-
Alleged racial discrimination in the pharmacy.
The article discusses a case filed before the U.S. District Court for the Middle District of Alabama on against a pharmacy by a patient for alleged racial discrimination. On April 2, 2005, an African American patient tried to buy from the defendant pharmacy, but she was snapped at by the pharmacist with harsh words of which patient interpreted as racial discrimination. The court ruled on the case that the conflict between the patient and of the pharmacist prevented dismissal of the case.
-
Andrew Irons and Michele Brown: A friendship and family collaboration.
The article discusses the collaboration of Doctor Andy Irons and Doctor Michele Brown to create an innovative pharmacy practice. Irons and Brown have agreed to create Bridge Project intended to help patients with diabetes meet their health goals. Also they organized the Lancaster Pharmacists for Improved Health Outcomes, wherein diabetes patients are given co-pay waivers and other incentives to enroll in the program through their employer.
-
APhA -APRS awards for contributed papers given at APhA2006.
Information about several papers discussed at the 2006 American Pharmacists Association Academy of Pharmaceutical Research and Science (APhA-APRS) Contributed Papers Poster Session held during the Annual Meeting and Exposition of the association in the U.S. is presented. The event provides presenters with an opportunity to display innovations and research in pharmaceutical and practice science. Furthermore , winners for various categories in the poster session is also presented.
-
APhA breaks ground for headquarters renovation.
The article reports on the groundbreaking ceremony for the launching of the construction of the new American Pharmaceutical Association headquarter on September 14, 2006 in Washington D.C. The ceremony also tackled the story behind the original structure, the pharmacist's place in history and the importance of the pharmacy's presence on the National Mall. The building, which is expected to be completed in 2009, will include a botanical garden, a rooftop terrace and a history hall for educational exhibits.
-
APhA e-Communities take off.
The article reports on the launch of the two electronic communities, Medicare/Medication Therapy Management Services and Nuclear Pharmacy, by the American Pharmacists Association for its members in the U.S. It states that electronic communities are Internet-based forums that allow pharmacists to share expertise and ideas on pharmacy issues with other pharmacists around the country. It presents the topics discussed in the networks and the planned network expansion of the organization.
-
APhA has moved!
The article reports that the American Pharmaceutical Association (APhA) has moved its location to 22nd Street, Saint Petersburg, Florida and Constitution Avenue, Washington D.C. due to the renovation of its old location which is expected to culminate in 2009. APhA executive vice president and executive officer John Gans expresses his pride for their new headquarters. The new mailing address of the association is presented.
-
APhA working for you.
The article offers news briefs related to the activities of the American Pharmacists Association (APhA). APhA introduces its new interactive Employment Center "My Site" to look for job opportunities, create and manage a personal profile or post a résumé. The Association's Books and Electronic Products Editorial Advisory Board met at Washington, D.C. in September 2006. Its Executive Vice President and CEO John A. Gans gave his speech about promoting safe drug disposal.
-
APhA working for you.
The article reports on the plan to require drug pedigrees to complete records of products have been and who has handled them starting on December 1, 2006. The measure aims to help pharmacists to do their part to protect patients from potentially fake and harmful products. According to Vice President for Policy and Communications Susan C. Winkler, the protection of our medication supply, including efforts to efforts to prevent the introduction of counterfeit products into the system.
-
APhA working for you.
The article offers news briefs related to the American Pharmacists Association (APhA). The North Carolina Supreme Court has agreed with the argument of the brief, which supports the 30-minute break and 12 hour shifts of pharmacists, that was filed by APhA. The association has organized a panel discussion on October 26, 2006 to discuss the support tools that will aid pharmacists. APhA has posted on its web site a list of frequently asked questions regarding the status of Plan B-Duramer/Barr.
-
APhA's Self-Care Institute celebrates its 5th anniversary.
Information about topics discussed at the 5th Annual Meeting of American Pharmacists Association Self-Care Institute (APhA-SCI) in the U.S. is presented. The meeting was participated by 70 faculty members from various pharmacy schools in the country. The meeting provided self-care teaching tools and strategies including active learning and explored the latest clinical information on emerging self-care trends and therapeutic topics.
-
APhA, AACP partner to enhance pharmacy career development resources.
The article reports on the partnership between the American Association of Colleges of Pharmacy (AACP) and the American Pharmaceutical Association (APhA) for its Career Pathway Evaluation Program for Pharmacy Professionals. AACP will join APhA for its survey of pharmacy professionals and to conduct research into the practice of pharmacy. According to Anne Burns, APhA Development and Research group director, the associations will work together to develop materials and training programs for schools and colleges of pharmacy.
-
Application now available for the 2006 API: Diabetes.
The article announces the availability of the applications for the "2006 Advanced Practice Institute: Diabetes" program. The program will give practitioners current information and strategies they can implement directly in their diabetes care practice to develop the level of care offered to patients and aid them manage their disease.
-
Assessment Questions.
An exam related to pharmacy is presented.
-
Bariatric surgery: Cure for the obesity epidemic?
The article focuses on the therapeutic use of bariatric surgery in treating overweight women in the U.S. The vertical banded gastroplasty and Roux-en-Y gastric bypass are the most common types of bariatric surgical procedures. This surgery is considered to be the most effective therapy for pathologic obesity. It caters weight loss and lessens type 2 diabetes in approximately 80 percent of the patients. However, the surgery is also associated with risk as with any major surgical procedure.
-
Beyond balm: Practical advice for chapped lips.
The article focuses on several causes of chapped lips. Patients experience chapped lips or angular cheilitis, an infection that causes deep cracks and splits to form on the lips and corners of the mouth, despite products which claim to treat chapped lips. Some of the causes include improperly fitting oral devices and physical habits. Health professional often remind patients not to lick, bite the corners of their mouths or suck their thumbs, in the case of children.
-
BOWL OF HYGEIA AWARD.
The article announces the Bowl of Hygeia awards given to pharmacists in the U.S. Among the recipients of the awards are Dr. Theodore G. Tong at the University of Arizona College of Pharmacy, H. Bernard Lebas who serves his community as a member of the Advisory Board at the University of Louisiana, and Thomas R. Dolan who has been very active in the Nebraska Pharmacists Association.
-
BOWL OF HYGEIA AWARD.
The article announces the Bowl of Hygeia Award given to several pharmacists including Trish White, Patrick L. McKercher, and Robert Treitline.
-
BOWL OF HYGEIA AWARD.
The article reports on the 200 recipients of the Bowl of Hygeia award program developed by the A. H. Robins Co. to recognize the outstanding service of pharmacist in the U.S. The winners were selected through their professional associations. The pharmacists include Betty Susina, Richard Hascup, and Roland Reznicek.
-
BULLETIN.
The article offers news briefs related to the pharmaceutical industry in the U.S. In its latest update, the Pharmacy Manpower Project's Aggregate Demand Index indicates a shortage of pharmacists in several states. A survey found that most women with osteoporosis considers the ability to prevent fractures when purchasing medication. Higher dosage hemagglutinin per influenza has been found to yield significant higher anti-body levels for older people.
-
Can anything be done?
The article offers information about head lice and tips on how to prevent children from having them. Head lice are gray or brown parasites which are about the size of a sesame seed. Female head lice lay about six eggs which usually hatch in about 8-10 days. Children should avoid sharing personal hair items and lockers at school. Several ways to identify the presence of head lice were also discussed.
-
Carmona thanks USPHS pharmacists when stepping down as surgeon general.
The article reports on the letter of former U.S. Surgeon General Richard H. Carmona given to the U.S. Public Health Service pharmacists when he left the office. In the letter, he acknowledge appreciation to all officers for their service and esprit de corps. According to him, the service of his companions help ensure that more children can learn, grow and prepare themselves for a healthy and productive adulthood.
-
Check suspensions for uniform dispersion.
The article focuses on a report submitted to the Institute for Safe Medication Practices in the U.S. It involves the failure of an attending pharmacy staff to shake well a carbamazepine suspension which was prepared in small bottles. It resulted to the irregularity of the suspension which allegedly caused the recurrence of seizures to the epileptic patient. It therefore advises pharmacy staff to shake suspensions well to avoid similar incidents in the future.
-
Cipro not always the best choice for pneumonia.
The article reports on the affirmation of the pharmacists and physicians from Wake Forest University that augmenting standard antibiotic therapy with the use of broad spectrum antibacterial for pneumonia is not the best choice. James R. Beardsley and colleagues stated that the guidelines recommending either aminoglycoside or flouroquinolone to beta-lactam therapy for empiric Gram-negative coverage, with the addition of ciprofloxacin does not improve the antibiotic coverage.
-
CMS ensures access to medications for entire plan year.
The article focuses on the amendments made by the U.S. Centers for Medicare &Medicaid Services (CMS) regarding its policy on Medicare Part D drug formularies which was considered to be disadvantageous to Medicare beneficiaries. Through the amendments, the plans will no longer be allowed to change their formularies within the plan year to guarantee that the beneficiaries who are enrolled in the Part D plan can continue accessing their medications for the whole plan year.
-
Cold sores: More than uncomfortable, embarrassing.
The article offers information about cold sores. It was reported that 100 million Americans each year are suffering from these painful, contagious, and unsightly eruptions. Since cold sores cannot be cured, available treatments focus on symptom relief and prevention of further spread. It is also known as fever blisters or herpes labialis infections, caused by the herpes simplex virus type 1.
-
Community pharmacy residencies: A road increasingly traveled.
The author reflects on the proliferation of community pharmacy residents in the U.S. He made an assurance that the pharmacists are becoming available to the community pharmacies in response to the demands of Medicare Part D and medication therapy. He pointed out that the residents learn their obligations to enhance the knowledge base of the profession and share it with their colleagues. This resulted to the increasing numbers of community pharmacy residencies in the country.
-
CORRECTION.
A correction to the article "Shortage of Pharmacists Reaching Critical Levels," that was published in the October 2006 issue is presented.
-
Correction.
A correction to the article "New guidelines support increased statin use for secondary prevention," that was published in the August 2006 issue is presented.
-
Counseling on the stimulant medications.
The article reports on the use of counseling to teach parents regarding the use of stimulant medications in treating attention-deficit/hyperactive disorder (ADHD). The medication has been found to improve behavior of children by decreasing hyperactivity, impulsivity, and inattention. In one study, ADHD has been found to affect boys three times more often than girls. The common adverse effects of medication were also discussed.
-
Counseling, drug information available to non-English speakers.
The article focuses on Walgreens Inc.'s multilingual services for its pharmacy customers that are not fluent in English. According to the author, the company offers counseling and drug information services in 17 languages including Vietnamese, Arabic, and Chinese. The article also cites some studies on the effect of language barrier on drug prescription.
-
Cuban sugar cane wax: New study challenges old assumptions.
The article discusses the efficiency of policosanol extracted from Cuban sugar cane wax in lowering cholesterol in patients with hypercholesterolemia. Results of a trial published in the Journal of the American Medical Association, sugar cane wax did not lower low density lipoproteins (LPL), contradicting previous studies. Furthermore, the study showed that policosanol has short-term adverse effects to human beings such as nervousness, diarrhea, headache, and insomnia.
-
CVS pharmacists dedicated to patient care.
The article provides information related to pharmacy in the U.S. CVS Pharmacy's pharmacists were highly nominated at the annual Pharmacy Today One to One Counseling Recognition Program. CVS Pharmacy company recognized the importance of Medicare Part D. CVS pharmacists made effort to educate patients on the best choices of over-the-counter drugs.
-
Darunavir: Hope for treatment-experienced, clinically advanced HIV patients.
The article evaluates the drug Darunavir (Prezista), which is a treatment of HIV-1 disease, manufactured by Tibotec.
-
Dasatinib OK'd for CML resistance, intolerance.
The article evaluates the drug Dasatinib (Sprycel), for the treatment of chronic-phase, accelerated-phase chronic myeloid leukemia, by Bristol-Myers Squibb Co.
-
DEA registration fee rising to $551 for practitioners.
The article reports on the increase of the registration fee for Drug Enforcement Administration's (DEA) renewal practitioners in the U.S. The increase has been to avoid a $185 million shortfall in funds for DEA's Diversion Control Program, which has also been required by the federal law to cover all costs with registration fees. DEA registrants who will experience the rise include manufacturers, distributors, chemical retailers and others.
-
Decitabine approved to treat myelodysplastic syndromes.
The article reports that the U.S. Food and Drug Administration approved the use of decitabine injection for the treatment of patients with myelodysplastic syndromes. With the incorporation of deoxyribonucleic acid (DNA), Decitabine would exert its antineoplastic effects that cause hypomethylation of DNA and apoptosis. The efficacy and safety of the so-called drug was proven through three clinical trials.
-
Design a superbill for your MTM practice.
The article offers advice to pharmacists on how to design a superbill for their medication therapy management (MTM) services. It is advisable to check out the superbill of other health care providers and create something similar. In designing a superbill, it is necessary to include the new current procedural terminology codes for MTM services, as well as the healthcare common procedure coding system for any tests performed and injections administered.
-
Diabetes 2006: An update for pharmacists.
The article provides updates for physicians regarding diabetes and its treatment. According to physician Carol Wysham, health care providers must consider multihormonal factors aside from the insulin resistance and deficiency in patients. The report also new pharmacological characteristics of antidiabetic drugs including sitagliptin phosphate which lowers the glycosylated hemoglobin concentration.
-
Diabetes Ten City Challenge: Update.
The article discusses on the Diabetes Ten City Challenge established by the American Pharmacists Association (APhA) Foundation in the U.S. The project is participated by 10 employer groups that support the implementation of the Patient Self-Management Program for diabetes organized by the ApHa Foundation. The employers provide payments to pharmacists for diabetes medications and health care services. Community pharmacists have been assigned to each site giving medical care to diabetes patients.
-
Don't take substitution suggestions on faith.
The article offers tips on how to avoid inappropriate generic substitutions. It states that the first strategy to avoid the mistake is to review the label of the drugs, and if necessary, physicians must request the indication for the prescribed medications. It also suggests to check the patients' allergies caused by the drugs taken and the importance of asking their conditions on the drugs they take.
-
Drugs, devices address glycemic variability.
The article offers information on the Annual Scientific Sessions of the American Diabetes Association (ADA) held at Washington, D.C. Thousands of physicians, scientists, pharmacists, and other health professionals attended the meeting which highlighted new devices, formulations, and medications, as well as information on the important concept of glycemic variability and other pharmacy-relevant developments in treating and managing diabetes.
-
Education and integrity.
The author reflects on the challenges that the pharmacist face and the implications of protecting the pharmacist and his practice against financial lure that puts professionalism at stake. The author inferred that pharmacists with different specialties acquire information to help patients, to maintain their practices financially viable, and to prevent courtroom or pharmacy board hearings. He believed that the pharmacy profession has met the challenges of using knowledge with integrity.
-
ELECTION.
The article reports that ballots for the American Public Health Association (APHA) Board of Trustees and the APHA Academy of Pharmacy Practice and Management and APHA Academy of Pharmaceutical Research and Science leadership have been mailed to the members by August 31, 2006. Members of the association have the chance to shape the future of APHA by voting for president-elect, trustees and honorary president.
-
Elephant Pharmacy caters to all.
The article profiles Elephant Pharmacy, a pharmacy founded by Stuart Skorman in Berkeley, California in December 2001. The company aims to promote a healthy lifestyle and provides a place for the patients to find healthy products. It has a small counseling room where patient and pharmacist can have a private chat. It is considered to be a remarkable place among the patients who are interested in herbal remedies. Moreover, it has become successful due to its medication options for the patients.
-
FDA moving ahead to combat counterfeit meds.
The article reports on the initiative of the Food and Drug Administration (FDA) in protecting people from counterfeit medications. The protection of medication supply, including efforts to prevent the introduction of counterfeit products, is important to pharmacists, both consumers and health care professionals. In this regard, FDA introduces the drug product pedigree which fully implements the Prescription Drug Marketing Act of 1987 on the advice of its Counterfeit Drug Task Force.
-
Federal pharmacists, technicians rally to 'transform patient care'.
Information about the 10th annual Combined Forces Pharmacy Seminar that was held on October 23-26, 2006 in Atlanta, Georgia is presented. Participants of the seminar include federal pharmacy professionals and technicians. The event's theme focuses on the improvement of the support of pharmacy to patient care. Several speakers have shared insights regarding the challenges facing pharmacists in the armed forces.
-
FEDERAL PHARMACY.
A photograph of the attendees of the Federal Pharmacist Advisory Committee quarterly meeting is presented.
-
Fixing what's wrong with American health care.
The article focuses on steps to improve healthcare in the U.S., as addressed by keynote speaker John Miall at the 2006 Pinnacle Awards on June 13, 2006. Miall challenged pharmacists to understand the costs and incentives in healthcare, assess the unnecessary investments, utilize management strategies, innovate new techniques and entertain new partnerships.
-
Go online to help patients with special needs.
The article features the disabilityinfo website brought by the federal government. The website, which gained information from hundreds of organizations, allows patients with disabilities including elderly or chronically ill patients who may not self-identify as disabled and their respective caregivers access to resources on health, employment, education and education.
-
Go south, young man: Kerr Drug pharmacist building on Operation Diabetes, Asheville Project.
The article focuses on the efforts of Ronald J. DeVizia Jr., doctor of pharmacy, to lead a team of pharmacists who offer a variety of medication therapy management and diabetes education services to patients at Kerr Drug Inc. pharmacies. He has been a coordinator for the American Pharmaceutical Association's Academy of Student Pharmacists Operation Diabetes project, and had his eyes opened to the many aspects of diabetes education. Recently, he has been promoted to manager of diabetes services.
-
Heart care costs likely to plunge as Pravachol, Zocor competitors emerge.
The article discusses the declining heart care costs in the U.S. Pharmaceutical industry analyst Decision Resources Inc., a firm that specializes in creating reports on drug therapies, projected that generic competition will reduce statins' share in market for coronary heart disease treatment from 55% in 2004 to 33% in 2014. Analysts assumed a switch to generic lovastatin for all Part D beneficiaries needing modest cholesterol reduction.
-
Heartburn meds: Interactions, contraindications important.
The article focuses on heartburn disease and different over-the-counter (OTC) medications for American patients. It has been estimated that 19 million patients take OTC medications, which include antacids, histamine-2 antagonists and proton pump inhibitors (PPI). Antacids neutralize stomach acid and alter the absorption of many indications. PPI can increase the half-life of dizepam, phenytoin and warfarin. However, certain patients should be discouraged from OTC heartburn medications for persistent heartburns.
-
Helping patients by helping physicians craft policy.
Information about the 2006 annual meeting of the American Medical Association (AMA) in the U.S. is presented. The AMA House members debated several issues which affect pharmacy practice which brought concerns to the American Pharmacists Association (APhA) including the conscientious refusal to dispense, compounding, and vaccine purchasing and administration. APhA member Margaret Tomecki appeared before the AMA committees to present pharmacy perspectives and input for AMA's consideration.
-
Helping patients with lifestyle choices, diabetes care.
The article discusses the importance of U.S. pharmacists in providing health care to patients with diabetes, hyperlipidemia, and hypertension. Pamela C. Heaton of the and Stacey M. Frede, both of the University of Cincinnati, suggested that pharmacists are acceptable as the most accessible health care providers and counselors to patients. Pharmacists are considered efficient in promoting health because they are highly trained in patient counseling techniques.
-
Herbal cough and cold products: Safe for kids?
The article discusses the safety and effectiveness of the three common herbal products used to treat common colds in children in the U.S. Andrographis panicula, which is the most important medicinal plants, may have the capacity to prevent and treat upper-respiratory infections in pediatric patients. Echinicea also has the capacity to diminish the severity and length of common colds in children.
-
HHS National Advisory Committee issues report on rural pharmacy.
The article discusses the National Advisory Committee on Rural Health and Human Services' 2006 report providing information on the state of rural health and human services in the U.S. The information offered by the agency highlighted problems in financial access to drugs and pharmaceutical services and how the Medicare Part D program affects rural patients and their pharmacists.
-
Holiday wishes.
The author presents his wishes for the pharmaceutical industry in the U.S. He wishes for the Congress to show a commitment to real medication therapy management. He hopes that prescription drug plans will stick with evidence-based practice. Also, he wishes for a continued collaboration among pharmacy associations.
-
HONOR.
The article reports on the Labor Hall of Fame Induction Ceremony that was held on November 16, 2006 in Washington, D.C. David Bernauer and Kevin Walgreen from Walgreen Co. have accepted the award commemorating the induction of Charles R. Walgreen into the Labor Hall of Fame. Charles R. Walgreen founded the pharmacy chain Walgreen Co., which currently employs almost 200,000 people.
-
HONOR.
The article that American Public Health Association member Anthony Palmieri III has received a plaque of recognition for his contributions to the field of pharmacy. He was awarded for his dedication as the International Steering Committee chair and member, laboratory project head and monograph author of the "Handbook of Pharmaceutical Excipients."
-
House subcommittee hearing focuses on supply chain security.
The article reports on the hearing conducted by the House subcommittee on Criminal Justice, Drug Policy and Human Resources in Washington regarding drug supply chain security. Subcommittee investigated because of counterfeiting of drugs such as Epogen, Procrit, Lipitor, Ortho Evra and some contraceptives. In combating the counterfeiting of drugs, the task force recommended developing radio frequency identification systems.
-
HPV vaccine could save millions of lives.
The article offers information on the human papillomavirus vaccine (Gardasil) manufactured by Merch &Co. Inc. Gardasil has been found to prevent cervical cancer and genital warts. The U.S. Food and Drug Administration licensed the vaccine for girls and women from between 9 to 26 years old. Researches explained that the vaccine should be administered before puberty or sexual activity to avoid the increased risk of infection.
-
Humana MTM program operates nationwide.
The article focuses on the adoption of the medication therapy management (MTM) services by Humana Inc. The company's health care plans offer an MTM program that communicates with plan members by mail, in person and by phone. Its call center provides a medication counseling line for patients and allows the staff pharmacists to follow up on drug issues. It has introduced an outreach campaign to help the members understand the things should be done in approaching the gap in Part D coverage.
-
ICAAC 2006: More questions, more research needed.
Information about the 46th Interscience Conference on Anti-microbial Agents and Chemotherapy held in San Francisco, California in September 2006 is presented. During the conference, several questions were raised and answers obtained concerning the antibiotic restriction. It discusses on the incidence of Streptococcus pneumoniae infections with variable penicillin susceptibilities. It was found out that the antibiotic exposure hastens the risk of Clostridium difficile colitis.
-
Immunization Summit gives insight into compensation.
Information on topics presented during the "Pharmacy-Based Immunization Summit: Partnering To Improve Access to Quality Healthcare" annual gathering which was held on September 13 to 14, 2006 in Arlington, Virginia are discussed. The summit, which was sponsored by the American Pharmaceutical Association and the National Associations of Chain Drug Stores Foundation, provided pharmacists with key elements to help them increase patient access to immunizations and develop strong payer-provider relationships.
-
Implanon: Contraceptive implant now available.
The article features the contraceptive drug Implanon. The drug is available for long-term contraception in the U.S., after having proven efficacy and safety in millions of women in numerous countries. The barely-noticeable, matchstick-sized single rod implant lasts 3 years and only needs a small surgical procedure for implantation and removal.
-
IN THE NEWS.
The article offers news briefs related to pharmacy in the U.S. Merck launches its new Merck Adult Vaccination Program for adults. Joint Commission Resources and the Institute for Safe Medication Practices present a program that teaches tactics in medication reconciliation. Food and Drug Association announces the launching the Human Subject and Bioresearch Monitoring Initiative as part of its plan in modernizing its clinical trial studies and sites.
-
IN THE NEWS.
The article presents health-related news briefs worldwide. A clinical trial has shown that telephone counseling can improve quality of life for lung transplant candidates. A study presented at the American Society of Clinical Oncology meeting revealed that the addition of thalidomide to standard therapy of melphalan and prednisone betters overall survival. A double-blind randomized controlled trial presented that patients with mild asthma can use breathing techniques to stop inhaler use.
-
Influenza Summit reports adequate vaccine for most groups.
The article reports on the accessibility of influenza vaccines for the 2006-2007 flu season in the U.S. Vaccine manufacturers attending the Influenza Vaccine Summit held in June 2006 revealed that almost 100 million doses of flu vaccines are available during the occurrence of the disease. Summit attendees focused on the provision of influenza immunization and the increase number of health care workers who will cater the needs of the people.
-
Inhalation capsules mistaken for oral capsules.
The article reports on Foradil and Spiriva inhalation capsules that are mistakenly taken as oral capsules in the U.S. Foradil is used to treat asthma and chronic obstructive pulmonary disease (COPD) while Spiriva is an anticholinergic bronchodilator used also for COPD. Several factors that contribute to the ineffective medication of the drugs have been reported. Recommendations for proper prescription to prevent similar medication errors are also presented.
-
IOM calls for changes to provider payment.
The article reports on the proposed pay-for-performance system for health services in the U.S., as recommended by the members of an expert panel assembled by the Institute of Medicine (IOM). The proposal is written in the IOM report titled "Rewarding Provider Performance: Aligning Incentives in Medicare." Physicians and pharmacists are the concerns of the payment system, whose objective is to improve safety, effectiveness, patient-centeredness and equity of care.
-
IOM issues a call to action on medication errors.
Seven steps to fewer medication errors
-
ISMP and FDA join forces to eliminate use of error-prone abbreviations.
The article reports on the elimination of error-prone abbreviations conducted by the Institute for Safe Medication Practices (ISMP) and the Food and Drug Administration (FDA) in the U.S. The two agencies have exerted effort in prohibiting shortcuts used by medical personnel because it could lead to misinterpretation. Misunderstanding of shortcut could lessen the quality of medical services and could harm the life of patients.
-
Isotretinoin prescription-filling restrictions eased.
The article offers information on the new update of iPLEDGE, a risk management program in the U.S. whose goal is to reduce the risk of fetal exposure to isotretinoin, an antiacne drug. Potential non-child-bearing men and women will be provided with a monthly supply of medication, with the condition that they wait more than seven days after their visit to the physician for prescriptions. New prescription and requalification for iPLEDGE are required in order to confirm that they meet the criteria.
-
JAPhA gets new Web host.
The article reports on the transfer of the contents of the American Pharmaceutical Association's (APhA) practice journal to the MetaPress hosting site. The move is to alleviate access problems that have been encountered by some institutional users in attempt to log in as APhA members or Journal of the American Pharmacists Association subscribers. The contents will be available on the MetaPress site, both in HTML and PDF files.
-
Jaw necrosis linked to bisphosphonate use.
The article discusses the study on osteonecrosis of the jaw as an adverse effect of bisphosphonates. The pathological explanation of the disease was reviewed in the "Annals of Internal Medicine" journal. According to the review, osteonecrosis were diagnosed to appear mostly on patients who are undergoing intravenous, nitrogen-containing bisphosphonates treatment.
-
JOIN US.
The article reports on the initiative of the journal to recruit volunteers who have knowledge in pharmacy to join on its editorial advisory board. The participants will serve as an expert reviewer for articles, act as critic on issues and suggest recommendations and provide topic suggestions. Board members will serve for three years and will begin in March 2007.
-
Judge: 'Compounded drugs are explicitly exempt from the new drug definition'.
The article reports on the findings of Robert Junell, judge of the U.S. District Court for the Western District of Texas, involving the U.S. Food and Drug Administration (FDA). According to Junell, FDA is unauthorized to require medications prescribed for a patient to go through the new drug approval process. He states that FDA must establish cause before inspecting a pharmacy's files and facilities and that the agency cannot enforce policies that make compounding drugs for nonfood animals from bulk ingredients illegal.
-
Know your school's accreditation status and what it means.
The article reports on the revisions made to the process and standards for colleges and schools accredited by the Accreditation Council for Pharmacy Education (ACPE) in the U.S. Information on instructions on the revisions are provided in ACPE's Web site, which is www.acpe-accredit.org. Key information on how to access the Web site are also presented.
-
Latest Project Urn PACT takes aim at depression.
The article discusses the Project Improving Persistence and Compliance with Therapy (IMPACT) program established by the American Pharmacists Association in the U.S. Project IMPACT is designed for patients diagnosed with depression and are under drug medication. Pharmacists provide medication evaluation, treatment, and monitor the patient's condition. The program also helps in identifying the effectiveness of health care services towards depression treatment.
-
Learn how to improve your diabetes care.
The article focuses on the Advanced Practice Institute: Diabetes forum by the American Pharmacists Association Foundation for pharmacists under diabetes patient care management. The faculty lectures, group discussion and interactive workshops in the forum provide practitioners with insights to improve their care strategies for patients and manage the disease more effectively.
-
Less than 10% of U.S. adults fully comprehend health information.
The article reports on the study conducted by the National Center for Education Statistics, which states that 53 percent of a comprehensive sample of Americans over the age of 16 were able to demonstrate intermediate health literacy. In addition, 22 percent of surveyed individuals had basic health literacy skills, as well as 14 percent had less than basic skills. Although intermediate health literacy skills is adequate for most health purposes, it is possessed by too few people.
-
Limiting expert witness testimony.
The article focuses on limitations for expert witness testimonies by patients against malpractice of pharmacists. Opinions made by experts are limited and should be based in scientific information and professional standards. Testimonies for liability and professional negligence cases are to be evaluated by courts in terms of their admissibility.
-
Looking beyond the red flags.
The article discusses the case of former police officer Richard Schleigh, who has been suffering from pain since his injury in 2002. This example aims to emphasize the responsibility of pharmacists in giving prescriptions for a controlled substance that raises red flags. The patient's previous medications were ineffective, but soon got relief from opioid as advised by his attending pain specialist. He claims that the accommodation shown by pharmacy staff has made his chronic pain less stressful.
-
Make time for MTM--work smarter, not harder.
The article offers tips in embracing the medication therapy management (MTM) services in the U.S. It has been suggested that the MTM services should replace something in the pharmacist's workload. The pharmacists are advised to make investments in line with technology. That they should operate more efficiently in electronic health. They should also acknowledge that not all their patients need or want the MTM services.
-
Making the most of our opportunities: Are you ready for American Pharmacists Month?
The author reflects on the American Pharmacists Month, which will be conducted by medical associations in the U.S. The author cites the goal of the month long celebration which is to inform consumers regarding pharmacist obligations to patients. He suggests that as pharmacists they have the responsibility to give additional information.
-
Managing Heartburn Symptoms in Patients Treated With Proton Pump Inhibitors.
The article focuses on the management of heartburn symptoms in patients under proton pump inhibitor treatment. Patients usually describe heartburn as a feeling of burning discomfort from the stomach of lower chest and travels towards the neck or throat. It is the most evident in gastroesophageal reflux disease and can be treated with proton pump inhibitors that act as acid suppression agents.
-
Managing medications during pregnancy.
The article discusses the medication management procedures on women diagnosed with manic-depressive disorder during their childhood who seek to become pregnant. According to studies, bipolar disorder is a chronic relapsing illness with a deteriorating course over time. Medical experts suggest that women with bipolar disorder should consider the impact of the illness and its treatment on their unborn child.
-
Many physicians remain uninformed about opioids.
The article discusses the survey which found out that many physicians lack the knowledge to prescribe the opioid analgesics appropriately. Based on the physicians' self-reports, fully 57% rated their knowledge on opioids was neither poor nor fair, and there were only 8 % responded that their knowledge of opioids was excellent. Also 88% responded that it was legal and acceptable for a patient with chronic cancer pain, when asked whether it is a legal to prescribe opioids for more than 6 months.
-
MARCH 16-19 APhA ATLANTA 2007 ANNUAL MEETING &EXPOSITION.
The article offers information on the annual meeting and exposition of the American Pharmacists' Association (APhA) on March 16-19, 2007 in Atlanta, Georgia. It includes a preview of the scheduled events and the list of companies, which have signed up for the exhibit. It likewise provides registration guidelines and fees for new practitioners, technicians, and students. Moreover, the early registration deadline will be on February 14, 2007.
-
Medi-CareFirst MTM program revving up.
The article focuses on the Medi-CareFirst prescription drug plan (PDP), which is a collaboration of CareFirst BlueCross BlueShield and Outcomes Pharmaceutical Health Care LLC. According to the author, independent, chain, and franchise pharmacies are trained to perform the Medi-CareFirst medication therapy management (MTN). The administration of the Medi-CareFirst MTN services program is discussed.
-
Medicare billing rules for DMEPOS changing.
The article reports on the accreditation for the suppliers of durable medical equipment, prosthetics, orthotics and supplies for seeking reimbursement under Medicare Part B in the U.S. for the year 2007. Suppliers must comply with newly established federal quality standards for business practices and customer services. Key information on the standards and a summary of the accreditation rules can be looked up at www.aphanet.org/medicare.
-
Medicare Part D information for pharmacists.
The article offers information on the Medicare Part D coverage and plans in the U.S. Medicare Part D plans are required to have a pharmacy technical support hotline for the first few months of 2007. Part D plans offer medication therapy management program to assist Medicaid beneficiaries who have multiple chronic diseases and spend more than $4,000 on annual medication costs. The plans provide 30-day temporary supply if the beneficiary is not transitioned to a formulary drug.
-
Medicare update: Information to share with patients.
The article offers information about the Medicare Part D plan including its services to its beneficiaries in the U.S. It has been stressed that the beneficiaries of the plan should decide whether to remain with their current plan or shift to another plan. It provides the eligible beneficiaries with the plan's options in which they will be responsible for the payment. It is pointed out that the beneficiaries with limited income and resources may qualify for the extra help with their drug costs.
-
Medication Therapy Management Services--Proceedings of the Pinnacle Roundtable Discussion.
Information about the 2006 Pinnacle Roundtable Advisory Board held in Washington, D.C. on June 14, 2006 is presented. The roundtable discussion explored the environmental factors that support the implementation of medication therapy management services and to help control the costs. The systems that are being developed to help these services were also reviewed. Its participants observed that the patients want more information regarding their health care than the previous generations.
-
Minimizing risk is essential.
The article discusses the study on minimizing the risk of gouty arthritis, a disease described as a painful inflammation of joints. According to the report, it has been discovered by the researchers in the 19th century that the disease is caused by the excessive production of uric acid leading to hyperuricemia.
-
Monitor closely or reconsider concomitant use of antidepressants, triptans.
The article reports on the call of U.S. Food and Drug Administration to manufacturers of the drugs such as triptans, selective serotonin, and nonepinephrine reuptake inhibitors, to add new warnings to product labeling. The agency has advised patients to use migraine-relieving triptrans and newer antidepressants in combination to speak with their health provider before discontinuing any medications.
-
More confusing drug names ….
The article reports on several misconceptions in treating different confusing drug names. A physician was involved in a mix-up of generic names flavoxate and fluvoxamine which complicated the patient's condition after taking the wrong drug. Physicians are advised to review prescriptions in terms of dosage and brand before dispensing any medicine.
-
More doctors means more prescribing errors for patients older than 65.
The article reports on the claims that older people acquiring prescriptions from two different physicians accounted an average of 27 prescriptions per year, with a risk of 10 potential prescription drug errors. The data were based on the press release by Medco Health Solutions Inc. On contrary, when five physicians assist the medical care, the prescriptions totaled up to 42, while the potential drug errors rose by 60 percent.
-
More problems with patches.
The article focuses on the burns suffered by the magnetic resonance imaging patients who are wearing transdermal patches. This could be the cause of the ferromagnetic metal objects that can be pulled at high speed by the magnet toward the patient. It was observed that the transdermal patches should also be removed before the scanning. It has been suggested that the patients should remove temporarily the patch to avoid of getting burned.
-
Most seniors can expect to experience a gap in Medicare drug coverage.
The article reports on the expected gap in Medicare drug coverage for the majority of senior citizens in the U.S., who will experience "doughnut hole" in Medicare drug prescription plans in 2006. The U.S. House of Delegates Committee on Ways and Means disclosed that 88 percent of individuals without extra Medicare coverage will pay 100 percent of drug costs for expenditure more than $2,250 and below $5,100.
-
MTM provider certification will soon be available from APhA and ASCP.
The article reports on the effort of American Public Health Association and the American Society of Consultant Pharmacists in providing the finishing touches on a medication therapy management certificate program. The program, which is fully accredited by the Accreditation Council for Pharmacy Education, includes both self-study and in-person training. Case studies and practical exercises will gear up pharmacists to conduct comprehensive medication reviews.
-
MTM Tip of the Month.
The article examines the need of patients with metabolic syndrome for medication therapy management (MTM) services in the U.S. Metabolic syndrome has been used to describe with multiple chronic conditions that may increase a patient's heart disease. The American Medical Association states the billable MTM services improves health outcomes and treatment compliance in patients.
-
MTM Tip of the Month.
The article focuses on the increased implementation of medication therapy management (MTM) services and Current Procedural Terminology (CPT) codes in the U.S. It targets the acceptance of the codes by third-party payers and their accompanied employment to pharmacy. The MTM services CPT codes were created by the American Medical Association for pharmacists as Category 3 codes. It claims that a Category 1 status could be attained if their usage and importance are proven in the profession.
-
Multiple prescriptions for Schedule II controlled substances: The next chapter.
The article focuses on the multiple prescriptions for a specific Schedule II medication under the U.S. Drug Enforcement Administration (DEA). It could be noted that this practice conforms with the federal requirements that the prescriptions yield the actual date that they are written. It tends to be beneficial when the patients are stabilized on a controlled substance. However, DEA emphasized that it is not encouraging the practice of issuing multiple prescriptions.
-
Nabilone, synthetic cannabinoid, available again.
The article reports that Nabilone (Cesamet), a schedule II synthetic cannanoid from Valeant Pharmaceuticals, has been returned to the U.S. market. The medication is used as an alternative for patients who failed other treatments for cancer chemotherapy-induced emesis which was originally approved by the Food and Drugs Administration in 1985. However, Nabilone was withdrawn for commercial reasons in 1989.
-
Navy pharmacy fosters responsibility, patient interaction.
The article focuses on the various professional growth opportunities experienced by Captain David E. Price in the U.S. Navy. Price's responsibilities span from being a stock boy, hospital corpsman, pharmacy technician, and currently as a pharmacist. He claims that the personal interaction involved in the occupation has made his job enjoyable. He likewise expressed pride on the influences he had towards the professional development of his staff.
-
New class, new treatment options for type 2 diabetes.
The article introduces Merck &Co. Inc.'s sitagliptin and Novartis Pharmaceuticals Corp.'s vildagliptin as new treatment options for type 2 diabetes mellitus. Sitagliptin can be taken alone or in combination with metformin or a thiazolidinedione to improve glycemic control in patients. Clinical trials of vildagliptin 100 mg it effectively reduces glycosylated hemoglobin values.
-
New edition of Medication Errors out.
The article reports on the release of the book "Medication Errors," second edition, edited by Michael R. Cohen. The editor solicited 30 experts from pharmacy, medicine, nursing and risk management to offer their insights about medication errors. The book provides insights on the causes of errors, such as drug names, packaging and labeling. Cohen is the president of the Institute for Safe Medication Practices.
-
New guidelines support increased statin use for secondary prevention.
The article discusses the results of the Treating to New Targets study and American guidelines to support the aggressive lowering of Low-density Lipoprotein Cholesterol. The study found that atorvastatin (Lipitor) from Pfizer can lower the risk of cardiovascular events by about 25 percents. Cororany artery disease patients are recommended to get a flu shot annually and quit smoking.
-
New HPV vaccine advised for 11-to 26-year-old girls and women.
The article reports on the recommendations for the newly licensed human papilomavirus (HPV) vaccine Gardasil from Merck &Co. Inc., presented at the U.S. Advisory Committee on Immunization Practices (ACIP) meeting on June 29-30, 2006 in Atlanta, Georgia. ACIP suggested that 11 and 12-year-old girls must take three doses of Gardasil vaccine prior to the onset of sexual activity.
-
New online masters program in regulation and policy.
The article reports on the new online masters program in regulation and policy on pharmacy. The program aims to educate pharmacists and others in health care for them to become effective advocates for appropriate medication use. Also it aims to put patient and the health care provider back into legal and policy discussions of pharmaceutical trade regulation by creating a cadre of well-educated and motivated representatives who will speak up for patients and health care providers.
-
New therapeutic agents marketed in the first half of 2006.
The article reports on the 14 new therapeutic agents marketed from January to June 2006 in the U.S. Twelve of them are classified as new molecular entities and 2 as biological agents. Six of the agents are used to treat conditions that occur infrequently and designated as orphan drugs. Product-specific information was obtained from product labels as approved by the Food and Drug Administration. A review of the therapeutic agents and their important properties are also presented.
-
News you can use.
The article offers news briefs related to health in the U.S. The American Pharmacists Association and Procter &Gamble Co. will run an extensive campaign to educate seniors about the Medicare Part D coverage gap. The Department of Health and Human Services is reviewing standards for electronic health records and other health data standards. The Food and Drug Administration has recalled acetaminophen 500 milligram caplets after small fragment metals were detected in some of the caplets.
-
No vacation for your Association!
The article reports on the activities conducted by the American Pharmaceutical Association (APhA) and the American Medical Association (AMA) in the U.S. AMA has considered several resolutions such as changing the influenza vaccine systems, halting reimbursement for compounded products and requiring pharmacists to call the prescriber when patients are referred to other pharmacists. Meanwhile, APhA gave a briefing to medical staff about medication therapy management.
-
NOMINATION.
The article provides information on the call for nominees for the American Pharmaceutical Association's (APhA) Board of Trustees and Academy Officer Candidates.
-
Oats, psyllium can lower cholesterol.
The article discusses the importance of oats and psyllium in the dietary meal of a person, based on the recommendation of the U.S. Food and Drug Administration. Oats is recommended as good source in reducing heart disease because it is rich in beta-glucan. Meanwhile, psyllium could lower cholesterol because it contains soluble and insoluble fiber. Psyllium is derived from the seeds of the plantago plant and used by Procter &Gamble Co. as a main component of its product Metamucil.
-
Office of Inspector General: Critical player in policy making.
The article focuses on the significant role of the U.S. Office of Inspector General by the Depart of Health and Human Services as the vital player in the country's policy making. The office has prioritized on significant issues such as inconsistencies in Medicare and Medicaid drug reimbursement calculations. It has set its audits and evaluations on disaster readiness to enhance the nation's defense against bioterrorism. It has been concentrating also to Medicaid integrity and quality of care.
-
Omnitrope approval clarifies issues raised by biogenerics.
The article reports on the clarification on issues related to biogenerics in the U.S. through the approval of the Sandoz Pharmaceutical Corp.'s recombinant somatoprin Omnitrope by the Food &Drug Administration. The agency classified the drug as follow-on protein product. The distinction of the biopharmaceuticals' therapeutic equivalence must be legally determined by the agency to provide consumers with low-cost drugs.
-
ONE TO ONE.
The article provides information on the nomination for the 2007 One to One Counseling Recognition Program, honoring pharmacists who have proven to be outstanding in the field of one-to-one patient care in the U.S. Nominees will receive a copy of the latest edition of the American Pharmaceutical Association's (APhA) Handbook of Nonprescription Drugs. The winners will receive airfare to Atlanta, Georgia for the 2007 APhA Annual Meeting with accommodations. Key information on how to nominate for this honor are presented.
-
ONE TO ONE.
The article announces the nominations for the 2007 One to One Counseling Recognition Program of the "Pharmacy Today." This program awards pharmacists who have proven themselves to be outstanding in the field of one-to-one patient care. The 10 pharmacists who will be recognized as winners will receive airfare to Atlanta, Georgia for the American Pharmacists Association (APhA) Annual Meeting. The other 10 honorable mentions will have a copy of the APhA's Handbook of Nonprescription Drugs.
-
ONE TO ONE.
The article announces the acceptance of nominations for the 2007 One on One Counseling Recognition Program. The program recognizes pharmacists who have proven themselves to be excellent in the field of one-on-one patient care. The 10 lucky pharmacists selected as the "Pharmacy Today" One on One Counseling Recognition Program winners will gained airfare to Atlanta.
-
Opioid analgesics linked to more deaths than heroin and cocaine combined.
The article reports on the efforts of CDC researchers analyzing deaths because of an unintentional drug poisoning between 1990 and 2002. They found out that narcotic painkillers are increasingly more likely to be the major cause. The team noted in an article published on a certain Website that between 1999 and 2002, the number of opioid analgesic poisonings on death certificates increased 91.2%, while heroin and cocaine poisonings increased 12.4% and 22.8%.
-
Part D at 6 months.
The article reports on the call of Representative Sherrod Brown for health care problems in the U.S. According to the author, the call of Brown at a House hearing, and the stakeholders' testimony, emphasize lurking problems with Part D. The author noted that some challenges are certainly pressing, which include the need to develop and enforce community-based medication therapy management services, and to even out the playing field for community and mail service pharmacies.
-
Part D plan marketing rules updated.
The article reports on the prohibition of cobranding of beneficiary identification cards when open enrollment in Medicare prescription drug plans resumes. Pharmacists and other health providers will be prohibited from recommending a certain plan in order to meet the needs of a senior or disabled patient. The continued plan, which federal regulators call steering beneficiaries to a plan has been kept because of concerns that providers may not have full information on all available plans.
-
Patents and patients.
The article reflects on the author's view on the need for medical manufacturers to give importance on patents for a better patient care in the U.S. According to him, his concern has been the quality and effect of a product and his patients' use of the product rather than the validity for the product's patent. He stresses that patents affect patients by supporting the development of innovative medications and allowing competition to drive prices down.
-
Patient Assistance Programs and State Pharmacy Assistance Programs in 2007.
The article focuses on the significance of Patient Assistance Programs (PAPs) and State Pharmacy Assistance Programs (SPAPs) for providing ways to supplement Part D coverage. PAPs offer financial assistance or free products to patients who fulfill the criteria. On the other hand, SPAPs help pay for prescription drugs intended for the low-income, senior, or disabled citizens. It has been permitted by the Modernization Act of 2003 to fill coverage gaps by the provision of wraparound benefits.
-
PGY1 community residency program standard gets a facelift.
The article focuses on the updated Accreditation Standard for Postgraduate Year 1 (PGY1) Community Pharmacy Residency Programs of the American Pharmacists Association and the American Society of Health-System Pharmacists. The revised version of the standard details the programs' capacity of training its residents. It describes the services that support the programs. Its main purpose is to establish criteria for systematic training in delivering patient-centered care and pharmacy services.
-
Pharmaceutics education studied.
Information about topics discussed at the American Association of Pharmaceutical Scientists (AAPS) educational workshop in Crystal City, Virginia is presented. The goal of the workshop includes identifying gaps in scientific technology, explaining why academic programs and technologies should be funded, and developing a paper to address the problems and provide recommendations. Workshop participants agreed that drug makers and biotechnology companies need to list their specific needs for PhDs.
-
Pharmacies' compounding practices get seal of approval.
The article reports on the achievement of the Pharmacy Compounding Accreditation Board's Seal of Accreditation by Homewood, Alabama-based pharmacy Compounding Shoppe and Apothecary Shops operating in Arizona and Las Vegas, Nevada. The seal shows that the two pharmacies passed the site inspection of the board and followed the written procedures for dosage forms.
-
Pharmacist liable for assaulting patient.
The article presents a court case involving a pharmacist who was found guilty of assaulting a patient in California. The details of the incident that leads to the exchange of abusive words and fist fight between the pharmacist and patient are presented. A jury awarded the patient $15,000 for the beating. The court stated that a plaintiff who establishes a case of liability is always entitled to compensatory damages as compensation for harm done by the defendant.
-
Pharmacist seeks to bridge gaps in patients' ability to understand.
The article discusses the efforts given by safety-net clinical pharmacist Sandra Leal in providing health literacy to patients. Health literacy is one of the major barriers being faced by pharmacists, it encompasses the understanding of every aspect of health care. Leal is a clinical pharmacy supervisor at El Rio Health Center, and her institution has used patient advocates, community lay workers and various health care team members to promote health literacy.
-
Pharmacist's monetary claim for denied breaks is dismissed.
The article reports on the lawsuit filed by a pharmacist against his employer in Washington wherein the former claimed that he be given additional wages for the meal and break periods being denied to him. The pharmacist purportedly chose not to take a break within his shift because the employer did not overlap pharmacists' shifts. However, the court reasoned that the pharmacist's decision not to take advantage of the meal break provisions did not entitle him to additional wages.
-
Pharmacists bill for services with National Provider Identifier.
The article reports on the adoption of the National Provider Identifier for health care providers in conformity with the Health Insurance Portability and Accountability Act of 1996. The new number, which will be effective for use on May 23, 2007, aims to recognize the medical services offered by pharmacists and their employment organizations.
-
Pharmacists stretch professional skills at sea.
The article reports on the medical assistance of the United States Naval Ships Mercy and Comfort to the U.S. armed forces. The deployed ships provide mobile medical and surgical services to the army and offer hospital services to government agencies connected in humanitarianism and disaster response projects around the world.
-
Pharmacists' expertise essential for guiding formulary decisions.
The article focuses on the importance of the expertise of pharmacists in protecting patients from drugs' adverse effects and in influencing decisions on drugs formulations and prescriptions. It states that pharmacists stand not only as drug administrators but also as primary protectors for the safety of the patients. As evidence, the experiences of Group Health Cooperative staff pharmacist Jennifer Hrachovec show how pharmacists used their drug expertise on pharmacy and therapeutics.
-
Plan B goes OTC.
The article reports that Plan B has gained approval from U.S. Food and Drug Administration, as an over-the-counter (OTC) emergency contraceptive for women aged 18 and older. Plan B, which known as the morning after pill, the first drug that will have dual status, wherein women older than 17 can obtain the product OTC. However, to those 17 years below are required to have a prescription to purchase the product.
-
Plan B: Pharmacy access means roles, responsibilities for pharmacy.
The article focuses on the role given to pharmacies in the distribution of Plan B, a levonorgestrel contraceptive by Duramed Inc., by the U.S. Food and Drug Administration (FDA). The American Pharmaceutical Association says that it believes that pharmacists are uniquely positioned to help manage access to emergency contraception under the pharmacy-access category. The only concern is that there is no rule on who will provide the patient with Plan B, as it may be a pharmacist, technician or cashier.
-
Plans are finalized for American Pharmacists Month.
The article discusses the preparation for the coming annual American Pharmacists Month. Members of American Public Health Association in Washington D.C. will enjoy pharmacists night at the Washington Wizards basketball team's preseason game. Although the event will be lighthearted, such collaboration reflects efforts by the Alliance for Pharmaceutical Care, to highlight the ability of the pharmacists to help prevent mistakes in medication.
-
Plans, pharmacies differ on timeliness of claims.
The article reports on the implementation of the new prescription drug benefit by pharmaceutical organizations in the U.S. Implementation of benefits is due to the Medicare Prescription Drug, Improvement and Modernization Act that signed in 2003. The American Pharmaceutical Association and the Centers for Medicare and Medicaid Services have endeavored the compliance of the program.
-
PQA: A pharmacy quality alliance dedicated to improving health care, patient safety.
The article reports on the formation of pharmacy quality alliance (PQA) for implementing quality services of pharmacists in the U.S. PQA members are responsible for ensuring pharmacists and pharmacies performances. The Alliance is comprised of organizations such as American Pharmaceutical Association, the National Consumers League and America's Health Insurance Plan to the Centers for Medicare &Medicaid Services.
-
PRODUCT SHOWCASE.
The article evaluates several medical-related products including Polyethylene glycol 3350 powder from Teva Pharmaceutical Industries Ltd., Ergowriter, for patients with osteoarthritis, from Maddak Inc., and the Fentanyl iontophoretic transdermal system from Alza Corp.
-
product showcase.
The article evaluates several health care products including the Prednisolone sodium phosphate oral tablets manufactured at Alliant Pharmaceuticals, Phospho-soda EZ-Prep for bowel-cleansing processes manufactured by Fleet Laboratories and Glutose-15 manufactured by Paddock Laboratories Inc.
-
product showcase.
The article offers news briefs related to pharmacy in the U.S. Sprycel of Bristol-Myers Squibb has gained full approval from Food and Drug Administration as a treatment for adults with chronic myeloid leukemia. Indication for Enzon's Oncaspar includes first-line treatment of children and adults with newly diagnosed acute lymphoblastic leukemia. Lavipharm has announced the availability of its generic fentanyl transdermal system.
-
PRODUCT SHOWCASE.
The article evaluates several products related to pharmaceutical industry including the Oxymorphone hydrochloride tablets for relief of acute pains from Endo, Cubist's daptomycin for treating Staphylococcus aureus, and the finasteride tablets from Teva.
-
product showcase.
The article offers news briefs related to drug approval in the U.S. Merck &Co. Inc. has announced the approval of vorinostat 100 mg capsule for oral treatment of cutaneous manifestations in patients with cutaneous T-cell lymphoma. The Donepezil hydrochloride 5mg and 10mg tablets have been approved for treatment of severe Alzheimer's disease. Mirapex pramipexole dihydrochloride tablets from Boehringer Ingelheim Corp. have been approved for treatment of primary restless legs syndrome.
-
product showcase.
The article evaluates prescription drugs including the Elaprase from Shire for the treatment of Hunter's syndrome, the Pylera from Axcan for the treatment of the Helicaobacter pylori infection, and Citracal Creamy Bites from Pharmacal as a nutritional supplement.
-
Profession celebrates American Pharmacists Month.
The article announces the third annual American Pharmacists Month held in the U.S. in October 2006. The pharmacists, student pharmacists and pharmacy technicians across the country celebrated the month with educational events, screening and other activities to establish relationships with patients and promote its value. The Minnesota pharmacy owners invited Congressman James L. Oberstar to visit Globe Drug in Grand Rapids. The McNeil Pediatrics in Pennsylvania held weekly giveaways.
-
PSSC welcomes new senior director.
The article announces that Harry Hagel has been appointed as senior director of the Health Resources and Services Administration department of the Pharmacy Services Support Center of the American Pharmacists Association (APhA) in the U.S.
-
Quality or commodity: The rest of the story.
The author reflects on the equality between health care system's quality and commodity in the U.S. He stressed that compromising care should be avoided though the price competition is serving the country's health well. He suggested that medication cost must be considered and medication use must be improved while seeking for the enhancement of its return on investment. He added that patient's understanding of their medications is necessary in improving the use of medication.
-
Rachel Henderson: Ensuring pharmacy's role in MTM.
The article features Rachel Henderson, a Giant Eagle pharmacist that uses residency as a springboard. She decided at the last minute to try an innovative residency program, one that featured several preceptors and three sponsoring organizations, instead of getting a high pay position in Ohio. She held sessions for the elderly at all Giant Eagle pharmacies in several cities in order to explain what was going on and discuss with Medicare beneficiaries about the new Medicare Part D benefit.
-
Rasagiline approved for Parkinson's disease.
The article reports on the approval of the U.S. Food &Drug Administration regarding the release of rasagiline, a monoamine oxidase type B inhibitor for the treatment of Parkinson's disease. The approval of rasagiline was based on the findings from 18 to 26-week clinical trials. The study revealed that discontinuation of therapy has adverse effects such as headache, hallucinations, arthralgia, and depression.
-
Reasonably accommodating a pharmacist's refusal to dispense.
The article presents the ruling of the Federal Courts in Wisconsin and Illinois in the case "Noesen v. Medical Staffing" and "Menges v. Blagojevich." The dispute in the cases involved the refusal of pharmacists to dispense oral contraceptives and emergency contraception because of religious beliefs. The Wisconsin case is dismissed while the Illinois case is still to be resolved by the federal court.
-
Recognizing excellence in patient counseling.
The article profiles John Vinson and Mario Zeolla, winners of the Pharmacy Today One to One Patient Counseling Recognition Program in the U.S. These pharmacists have earned recognition for being outstanding in patient counseling, going beyond the call of duty to help patients, and using their superior communication skills to improve health outcomes for patients.
-
Remembering our patients….
The article reflects on the author's view regarding the importance of keeping the value of medical providers or medical personnel's relationship with his patients. As the medical personnel or health provider one should always consider the welfare of their patient, that every medication dispensed is important to the patient's lives. Sometimes health personnel tend to lose track on their patient due the lull of their routine or work.
-
Residency program standard revised.
The article reports on the move of the American Pharmaceutical Association and the American Society of Health-System Pharmacists to update its Accreditation Standard for Postgraduate Year One Community Pharmacy Residency Programs. The update outlines the elements of a quality residency training program and details the types of services required to support a residency program. The accreditation will take effect in the fall of 2007.
-
Responsibility for MedGuide distribution.
The article focuses on the legality of the pharmacist's duty to warn the patients about the harmful effects of drugs using the MedGuides. Most of the jurisdictions in the U.S. held that a pharmacist has no generalized duty to warn a patient of possible adverse effects since this responsibility lies to the prescriber except for the "no duty to warn" policy. The requirement for MedGuides may lead to the pharmacists' legal liability for the failure of distributing them to the patients.
-
Right drug, right price.
The features the Consumer Reports Best Buy Drugs website. It is best suited to all pharmacists, patients, and prescribers looking effective, low-cost alternatives to brand name medications. It also offers analyses of therapeutically equivalent options in 13 drugs categories, ranging from ACE inhibitors and antidepressants to proton pump inhibitors and triptans.
-
Safety issues are often 'compounded' by many factors.
The article discusses the safety precautions that should be taken by physicians and pharmacists to ensure patient safety in giving compounded medications. Pharmacy compounding is a legitimate practice, but there have been several occurrences of deaths due to some errors in communication with patients as to the correct application and their potential dangers. The practitioners involved should discuss and document its purpose before prescribing or agreeing to dispense such compounded medications.
-
Safety net pharmacy 101.
The article reports on the health care services given by safety net pharmacy to uninsured patients in the U.S. Safety net aims in providing minimal cost of medical services and medications that are made affordable to patients. The 340B Drug Pricing Program provides access to reduced price prescription of drugs from among health care facilities. Pharmacists play a significant role in safety net which contributes in the development of efficient manage care to patients.
-
Saw palmetto for prostate enlargment.
The article offers information about the medicinal use of saw palmetto. The plant is commonly used by men in the U.S. to treat prostate enlargement and even in European countries, was used to treat for symptoms of benign prostatic hyperplasia. Its berries are use medicinally to treat urinary problems in men. However, clinical studies found out that its berry extract has not reduced prostate size, hence, benefits may be came from multiple mechanisms.
-
September is National Preparedness Month.
The article focuses on the National Preparedness Month. September is delegated as National Preparedness Month, and American Public Health Association decided to join the coalition. The measure will give no time for pharmacists, pharmacy technicians, and student pharmacists to make their own plans for dealing with natural disasters or terror attacks and to get their patients doing the same.
-
Shaping your role as a pharmacist?
The article presents the comments of pharmacists who receive the incentive grants. One pharmacist revealed that what he learned most from the project is the importance of developing a relationship with other health care providers. Another claims that he learned that it is possible to develop and implement beneficial services in any pharmacy environment.
-
SHIPs can help you help your patients.
The article offers information on the State Health Insurance Assistance Program (SHIP) that serves every state in the U.S. for Medicare Part D patients. The program offers personalized counseling and assistance the beneficiaries and caregivers under Medicare coverage. It also supports pharmacists in navigating the intricacies of Medicare Part D.
-
Shortage of pharmacists reaching critical levels.
The article focuses on the shortage of pharmacists and its implications, based from the data by the Pharmacy Manpower Project. According to the project's director Katherine Knapp, the continuous shortage of pharmacists will eventually affect patients' health. Over 150,000 is the estimated total shortfall of pharmacists in the U.S. by 2020.
-
SNOMED chosen as standard to flag potential drug use problems.
The article reports that the Standardized Nomenclature of Medicine (SNOMED) has been selected by the U.S. Food and Drug Administration (FDA) to match patient information with descriptions of serious adverse events and drug interactions in prescription drug labeling. Acting FDA commissioner Andrew C. von Eschenbach stated that the SNOMED would guarantee that all Americans will be able to have electronic health records and unify health information infrastructure in the country.
-
Sorting Out the Options for Self-Treatment of Heartburn and Dyspepsia.
The article focuses on the appropriate options for heartburn and dyspepsia self-treatment among the patients in the U.S. It describes the pathophysiology of both diseases. It offers the criteria which are used to differentiate patients who are candidates for self-treatment from those to be referred for medical evaluation. It explains the suitable use of antacids, histamins H2-receptor antagonists and proton pump inhibitors in the treatment.
-
Spirituality and health--two worlds converging.
The article focuses on the significant role of the pharmacists in the interaction between spirituality and health care. According to the American Academy of Family Physicians, there is a positive correlation the spirituality and health care results of a patient. It was found out that the prayer's relaxation response can have positive health effects on body conditions such as hypertension and insomnia. To further this remedy, practicing and student pharmacists should be aware of spirituality.
-
Strategies for communicating with primary care providers.
The article focuses on several strategies usable for pharmacists when communicating with primary care providers. The author asserted that pharmacists must identify the concerns of prescribers regarding pain control and treatment. They can do this by providing nationally recognized guidelines such as the "Pain Control in the Primary Care Setting" by the American Pain Society.
-
Student pharmacists honored with 2006 Mortar and Pestle awards.
The article announces the Mortar and Pestle Professionalism Award sponsored by McNeil Consumer Healthcare for student pharmacists who are members of the American Pharmaceutical Association-Academy of Student Pharmacist (APhA-ASP).
-
Successful precepting in a psychiatric hospital setting.
The article discusses the successful preception of pharmacist Philip C. Miller of his students during their hospital and psychiatric rotations at Promedica Health System in Sylvania, Ohio. According to the author, Miller has started the process by setting expectations for his students. He then assessed the performance of his students by giving them quizzes. Afterwards, he gave them descriptive and specific feedbacks.
-
Survey shows 'entrenched' pharmaceutical abuse among teens.
The article focuses on the Partnership for a Drug-Free America survey which shows the pharmaceutical abuse among teenagers. It is stated in the survey that two in five teenagers including Jason Surk, a second year prepharmacy student who is overdosed with generic methylphenidate, believe that pharmaceuticals are safer than illicit drugs. To prevent further abuse, the author discusses the educational campaign of the Consumer Healthcare Products Association which educates parents about drugs.
-
Surveys find MTM plans are limiting face-to-face patient contact.
The article reports on the problem concerning the implementation of medication therapy management plans in the U.S. Results of surveys show that the program limits the in-person intervention between the in-house pharmacist and the patient. Moreover, Medicare Part D plans do not follow the program criteria organized by the national pharmacy organization.
-
Taking ownership of MedRec.
The author comments on the ownership of medication reconciliation (MedRec) in the U.S. He claims that MedRec is a clear responsibility of the pharmacists who own MedRec. However, pharmacists do not own it and may never own it. He elaborates several reasons why pharmacists do not own the process. He ends that the American Pharmacists Association has formed a task force with the American Society of Health-System Pharmacists for the ramification of MedRec.
-
Taking the message to state legislators.
The article reports on the participation of the American Pharmaceutical Association during the promotion of the value of pharmacist's services to the recent National Conference of State Legislatures, as a part of the Alliance for Pharmaceutical Care. The Alliance exhibit, held in Nashville, Tennessee, made participants receive education and screening services. Meanwhile, a proposed rulemaking for health care practitioners are issued by the Department of Justice's Drug Enforcement Administration.
-
Telbivudine: Another option for active chronic hepatitis B.
The article evaluates Telbivudine, an oral nucleoside analogue that suppresses hepatitis B virus replication, from Idenex Pharmaceuticals Inc. and Novartis Pharmaceuticals Corp.
-
Temp work offers change, travel.
The article profiles Valerie Mull, a pharmacist from Connecticut. Mull worked in federal facility which she traveled from any state and even in other countries, serving for almost one year in the Virgin Islands where she helped a hospital pharmacy to be accredited by the Joint Commission on the Accreditation of Healthcare Organization. She believed that troubleshooting would be part of her career because she has the ability to take chances.
-
The antibiotic debate.
The article reports on the guidelines of treating acute otitis media. According to the American Academy of Family Physicians, antibiotics should be prescribed to children who have definite and severe illness. The guidelines recommended the use of high-dose amoxicillin 80 to 90 milligrams per kilograms per day divided into two doses. Alternatives to high-dose amoxicillin are also presented.
-
The pandemic defense.
The article discusses the significant role of pharmacists in health care preparation for future pandemics. According to an author, pharmacists play an active role in the preparation by becoming immunization advocates and conducting individualized immunization regimen for protection against preventable infections.
-
The Role of Pancreatic Enzyme Therapy in the Treatment of Cystic Fibrosis.
The article presents the home-study continuing education program for pharmacists on "The Role of Pancreatic Enzyme Therapy in the Treatment of Cystic Fibrosis," which was developed by the American Pharmacists Association in the U.S. The article has provided an overview of the program about cystic fibrosis, as well as the genetic considerations, pathogenesis and clinical manifestations, diagnosis, general treatment strategies, and the role of pancreatic enzyme therapy.
-
Too well connected? The downside of cell phones.
The article discusses the downside of using cellular telephones in the workplace. It cites instances how cellular telephones can be distractive and intrusive when used by pharmacists while at work. To prevent the problem, the author suggests to establish personal communications technology policies in the workplace. She says that having a general telephone policy and requiring employees to leave their cellular telephones in their cars and lockers are some of the best ways to overcome the problem.
-
Training materials available on ephedrine, pseudophedrine.
The article reports that training materials have been released by the Drug Enforcement Administration (DEA) in the U.S. The materials will allow pharmacies to certify their employees that have learned the new rules they must follow when selling products having ephedrine, pseudopherine or phenylpropanolamine. Community pharmacists are required to train their employees on the new requirements and must at least used the DEA materials in their training.
-
Triglycerides, HDL Cholesterol, and Other Secondary Targets of Lipid-Lowering Therapy.
The article presents a special report from the American Pharmacists Association (APhA) concerning triglycerides, high density lipoproteins (HDL), and other indicators of lipid-lowering treatment. The causes of elevated serum triglycerides and the different approaches of its treatment are given. It also discussed the criteria for clinical diagnosis of metabolic syndrome and the effects of niacin, fibrates, omega-3 fatty acids, and statins on serum triglycerides and HDL cholesterol levels.
-
Tysabri: Back on the market.
The article reports on the restricted distribution system approved by the U.S. Food and Drug Administration (FDA) for natalizumab (Tysabri) from Biogen-Idec Inc. Tysabri can only be dispense by pharmacies registered of the Touch risk management program of the FDA. The agency approved the drug for treatment of replapsing-remitting mulitple sclerosis which was withdrawn by the manufacture because patients are using the drug for other indications.
-
U.S. ephedra ban upheld.
The article reports on the move to carry on the ban imposed by the U.S. Food and Drug Administration on the sale of energy-boosting and weight-loss products with ephedra as an ingredient. This has followed after its conduction of a scientific and case-study review, which significantly found that dietary supplements with ephedrine alkaloids are not safe. The ban was suspended by a federal circuit court in Utah but has been overturned by the Tenth Circuit U.S. Court of Appeals in Denver, Colorado.
-
Using laxatives wisely.
The article provides some information on how to prevent constipation. The author emphasized that the use of laxatives is not always best cure for chronic cases of constipation. She stated that simple lifestyle changes are all that is required for most patients. Moreover, the author gave suggestions to determine constipation causes, on lifestyle change, and on over-the-counter drugs.
-
Valerian may help with sleeplessness.
The article examines the use of valeriana officinalis in treating insomnia and other sleeping disorders. The roots or rhizomes of the plant contains many active compounds including valepotraites, monoterpenes, and sesquiterpenes which are known components for its sedative effect. The use and side effects of valeriana were also discussed.
-
Vitamins/minerals: Unproven benefits, possible harm.
The article reports on the harmful effects of commercial multivitamins and minerals (MVM) as concluded by the National Institutes of Health (NIH) panel in the U.S. According to the NIH panel, these supplements are largely unproven therapies that may be harming some consumers. In one NIH meeting, the use of these supplements on specific patient types was thoroughly discussed.
-
VZV vaccine approved for shingles and postherpetic neuralgia.
The article reports on the approval of Zostarva, a variella-zoster virus live attenuated vaccine, in prevention of herpes zoster and postherpetic neuralgia. The chicken pox vaccine has been found to reduce the incidence of the HZ by more than 50 percent. Researchers explained that the increased potency of the vaccine is needed to stimulate immunity in older patients.
-
Web-based program broadens Medicare Part D services.
The article reports on the significance of web-based Community medication therapy management (CMTM) in the implementation of Medicare Part D plans in the U.S. The CMTM provides secure messaging service that delivers MTM cases directly to pharmacists. The Community Care Rx program utilizes the CMTM which offers various medical care opportunities to patients. In addition, it improves the relationship between community pharmacists and their patients by giving assistance to their medication needs.
-
Weight, injuries, and lifestyle contribute to osteoarthritis.
The article presents healthy lifestyle changes that reduce the risk of developing osteoarthritis. One of the most important steps in preventing osteoarthritis is the maintenance of a healthy weight. It has been reported that osteoarthritis of the knee is four to five times more common in obese people than in those of normal weight. Regular exercise programs that include range-of-motion workouts, muscle strengthening, and aerobic activities are also recommended to improve joint function.
-
Welcome to a new Today!
The article announces the changes undertaken in the "Pharmacy Today," journal. The redesigned publication offers in depth pharmacy news and information in order to cope up the fast changing world of pharmacy and health care. The most obvious element in redesigning the journal is the new size, where specific dimensions selected are those that best fit on the latest printing presses. Also, the interior pages have been changed in order to accommodate the requests of the readers.
-
What constitutes medication therapy management?
The author comments on the article that analyzes the Medicare Part D medication therapy management (MTM) services plans in the November/December 2006 issue of the "Journal of the American Pharmacists Association." The study showed that 70 different health plans were offering 21 different MTM programs covering about 12.1 million people. However, in nearly all cases, the health plan selects the patients who qualify for MTM services and then an intervention is made.
-
Winter skin care: Don't get chapped!
The article offers tips to keep the skin look as youthful and healthy as possible. Home humidifying systems within the heating ducts humidifies the air and prevent skin from drying out a well as from being cracked and itchy. Patients having skin problems are advised to apply sunscreen with sun protection factor of at least 15 to protect from harmful ultraviolet A and B rays. Long and hot showers should be avoided because they are not good for the skin though they may be relaxing.
-
Working to achieve better patient outcomes.
The article profiles Pharmacist Stuart Beatty, a clinical assistant professor at the Ohio State University College of Pharmacy in Columbus Ohio. He provides medication-related guidance to physicians for patient conditions. His pain management conditions allows his to guide the care of patient suffering form chronic pain. He explained physicians and residents look to him for suggestions and ideas.
Have a comment about this page?
Please, contact us. If this is a correction, your suggested change will be reviewed by our editorial staff.